|
简述老年心力衰竭治疗的循证医学研究进展 |
| |
nbsp;K, et al. Effect of candesartan in patients with chronic heart failure and reduced left ventricular systolic function taking angiotensinconverting enzyme inhibitors: the CHARMAdded trial[J]. Lancet, 2003, 362(9386):767771.
[16]Cranger CB, McMurray JJ, Yusuf S, et al. Effect of candesartan in patients with chronic heart failure and reduced leftventricular systolic function intolerant to angiotensinconverting enzyme inhibitors: the CHARMAlternative trial[J]. Lancet, 2003, 362(9386):772776.
[17]Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group. Effect of losatan and captopril on mortality and morbidity in highrisk patients after acute myocardial infarction: the OPTIMAAL randomized trial[J]. Lancet, 2002, 360(9335):752760.
[18]McMurray J, Solomon S, Pieper K, et al. The effect of valsartan, captopril or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) [J]. J Am Coll Cardiol, 2006, 47(4):726733.
[19]The Cardiac Insufficiency Bisoprolol Study Ⅱ(CIBISⅡ): a randomized trial[J]. Lancet, 1999, 353(9146):913.
[20]Effect of metoprolol CR/XL in chronic h上一页 [1] [2] [3] [4] [5] [6] [7] [8] [9] 下一页
上一个医学论文： 浅论老年心力衰竭伴心律失常的诊治
下一个医学论文： 4760例老年慢性心力衰竭住院患者病因变迁的调查
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文